Search for: "Astrazeneca" Results 1001 - 1020 of 1,246
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
12 May 2009, 11:43 am
The most prolific classification relates to medicinal preparations and cyclodextrins, whilst other classifications relating to medicinal, topical or cosmetic preparations occupy seven of the top ten places.Looking at sheer patent volumes, the main industrial filers are Tioxide, Pfizer, AstraZeneca and Philips. [read post]
11 May 2009, 8:23 am
Two of our Trends in 2009 also saw significant developments this week, with personalized medicine dealt a setback by Medicare’s decision  not to reimburse for  Warfarin dose testing  and innovative R&D in India getting a Jubilant boost from AstraZeneca. [read post]
5 May 2009, 5:57 am
"There's no evidence that AstraZeneca proffered a stronger warning that the FDA rejected. [read post]
23 Apr 2009, 10:00 pm
(Spicy IP) India: Assessing India’s innovation climate (Biotech Blog) Kenya’s anti-counterfeit legislation, India protest (Afro-IP) Mexico: Pharmaceutical trade marks: the Health Law pitfall for applicants (International Law Office) US: BIO IP Counsels’ Committee: Q Todd Dickinson and E Anthony Figg on patent reform (Patent Docs) US: Amgen VP makes case for longer exclusivity period in follow-on biologics legislation (Patent Docs)   Products Cepham –… [read post]
23 Apr 2009, 3:48 am
  AstraZeneca is currently under review by the FDA to have the drug’s use expanded to include patients of depression and anxiety. [read post]
21 Apr 2009, 8:20 pm
By Suresh Pillai -- AstraZeneca Secures Temporary Restraining Order in PULMICORT ® Case Last week, the U.S. [read post]
17 Apr 2009, 11:05 am
Such arrangements aren’t unprecedented, though: In 2007, AstraZeneca PLC and Bristol-Myers Squibb Co. struck a partnership to develop and market two diabetes drugs. [read post]
17 Apr 2009, 10:46 am
Temporary Restraining Order Pulmicort The US District Court for the District of New Jersey granted AstraZeneca’s request for a temporary restraining order, barring Apotex from selling a generic version of AstraZeneca’s Pulmicort Respules (budesonide inhalation suspension) until further order of the court. [read post]
16 Apr 2009, 11:20 pm
Full disclosure: Bexis has past (but not present) involvement in the defense of the Colacicco case.Earlier, in the Seroquel (atypical antipsychotic) MDL litigation, defendant AstraZeneca filed revised, post-Levine preemption briefs (initial and reply). [read post]
15 Apr 2009, 4:44 am
We've been doing some research in anticipation of the upcoming ALI meeting at which the Principles of the Law of Aggregate Litigation will be voted on (we hope ALI members interested in class actions and the like will come out, debate the issues, and vote), and in the spirit of cross-fertilization, we thought we'd share it with our readers. [read post]
9 Apr 2009, 4:55 pm by Carey, Danis & Lowe, L.L.C.
Lawsuits have been filed against AstraZeneca alleging that the drugmaker hid the dangers associated with Seroquel from patients and many were seriously injured as a result. [read post]
9 Apr 2009, 7:52 am
(Part I - Patent Circle) (Part II – Patent Circle) Indian biogenerics on an upswing – US Promoting Innovation and Access to Life-Saving Medicine Act (Patent Baristas) US: Anti-reverse payment legislation Protecting Consumer Access to Generic Drugs Act of 2009 introduced in the House (Patent Docs) US: CAFC clarifies obviousness standard in context of cDNA cloning invention: In re Kubin (Holman's Biotech IP Blog) (Patent Docs) (Hal Wegner) (Philip Brooks' Patent… [read post]
9 Apr 2009, 1:55 am
Be it Pfizer's (NYSE: PFE) Lipitor, Eli Lilly's (NYSE: LLY) Zyprexa, or AstraZeneca's (NYSE: AZN) Nexium, it's going to hurt when the drugmakers start to face generic competition. [read post]
6 Apr 2009, 1:11 pm by Carey & Danis, L.L.C.
AstraZeneca, the London-based company that makes the drug, wants the U.S. [read post]
6 Apr 2009, 10:24 am
The Seroquel side effects lawyers at Carey & Danis believe that AstraZeneca kept the dangers associated with Seroquel secret. [read post]
2 Apr 2009, 3:56 am
AstraZeneca LP Addressing the oft-raised (recently) issue of whether pharmaceutical sales representative employees are subject to the Outside Sales exemption, the District Court answered the question in the affirmative and granted Defendant’s Motion for Summary Judgment on the issue. [read post]
28 Mar 2009, 2:26 am
Examples Of Qui Tam Related Recoveries: $355,000,000 AstraZeneca $334,000,000 Amerigroup $325,000,000 HealthSouth $257,000,000 Bayer $155,000,000 Medco Health $49,000,000 Pfizer $26,000,000 Key West Pharmacy Qui Tam Web Resources: FALSE CLAIMS ACT CASES: GOVERNMENT INTERVENTION IN QUI TAM (WHISTLEBLOWER) SUITS Medicare Fraud HHS Takes Further Steps to Protect Medicare From Fraudulent Durable Medical Equipment Suppliers [read post]
28 Mar 2009, 2:26 am
Examples Of Qui Tam Related Recoveries: $355,000,000 AstraZeneca $334,000,000 Amerigroup $325,000,000 HealthSouth $257,000,000 Bayer $155,000,000 Medco Health $49,000,000 Pfizer $26,000,000 Key West Pharmacy Qui Tam Web Resources: FALSE CLAIMS ACT CASES: GOVERNMENT INTERVENTION IN QUI TAM (WHISTLEBLOWER) SUITS Medicare Fraud HHS Takes Further Steps to Protect Medicare From Fraudulent Durable Medical Equipment Suppliers [read post]
23 Mar 2009, 11:35 am
AstraZeneca has had this study stuffed away for 12 years. [read post]
23 Mar 2009, 11:35 am
AstraZeneca has had this study stuffed away for 12 years. [read post]